Feb 4 (Reuters) - Industrial equipment maker IDEX Corp IEX.N reported a better-than-expected quarterly profit on Tuesday, driven by strong sales of its health and science technology segment products.
Quarterly sales in IDEX's health and sciences technology segment, which includes components and equipment used in clinical diagnostics and drug discovery, as well as in the food processing and cosmetic manufacturing industries, rose 19.3%.
The rise in demand was led by sellers seeking to replenish inventories following an extended destocking cycle triggered by large stockpiles during the COVID-19 pandemic.
Quarterly adjusted earnings per share stood at $2.04, compared with Wall Street estimates of $2.02, according to data compiled by LSEG.
Total revenue for the fourth quarter ended Dec. 31 was $862.9 million, up about 9% from a year earlier. Analysts, on average, were expecting revenue of $863.8 million in the fourth quarter.
(Reporting by Aishwarya Jain and Nathan Gomes; Editing by Mohammed Safi Shamsi)
((Aishwarya.Jain@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。